Abbott, Dexcom, Insulet, Medtronic and others are developing next-gen sensors, pumps and algorithms for type 2 diabetes ...

Nearly 40% of patients diagnosed with type 2 diabetes imperil their health by stopping their medication within the first year ...

A study confirms Raman Spectroscopy’s potential for noninvasive glucose monitoring, improving calibration and accuracy.

First Update in Nearly 10 Years by FITTER Forward Initiative Sets Out to Transform Insulin Injection Technique EducationPARSIPPANY, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") ...

Vertex continues to develop type 1 diabetes therapy, zimislecel, which is being investigated in a Phase III trial.

ATTD conference, experts debated whether patients who use continuous glucose monitoring should aim for normal glycemia.

The use of an automated insulin delivery (AID) system reduced A1c and hyperglycemia without increasing hypoglycemia in people ...

The global diabetes care devices market is poised for substantial expansion, with projections indicating a rise from USD 64.5 billion in 2024 to an impressive USD 117.7 billion by 2034. The market’s ...

Scientists at the Łódź University of Technology in central Poland have developed a new light-based therapy device designed to support home treatment of diabetic foot syndrome, a serious ...

Our extensive research on the Europe Diabetes Care Devices (2024-2032) offers valuable insights for businesses. This comprehensive report delves into emerging trends, investment opportunities, ...

Nearly 40% of patients diagnosed with type 2 diabetes imperil their health by stopping their medication within the first year, diabetes experts warn.